FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Alzheimer's related Press Releases

New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth

Posted June 17, 2009

New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimer's Disease Market Sales of Acetylcholinesterase Inhibitors,... Read more...

Twin study: Diabetes significantly increases risk for Alzheimer's disease and other dementia

Posted January 28, 2009

Twin study: Diabetes significantly increases risk for Alzheimer's disease and other dementia Getting diabetes before 65 more than doubles risk for Alzheimer's disease Diabetics have a significantly

... Read more...

Antipsychotic drugs double risk of death among Alzheimer's patients

Posted January 9, 2009

Antipsychotic drugs double risk of death among Alzheimer's patients New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication

... Read more...

GlaxoSmithKline, AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimera's disease candidate vaccine

Posted October 23, 2008

GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimera's disease candidate vaccines GlaxoSmithKline Biologicals S.A. (GSK) and AFFiRiS GmbH announced

... Read more...

AstraZeneca PLC (AZN) and Targacept, Inc. (TRGT) Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Diseas

Posted September 16, 2008

AstraZeneca PLC (AZN) and Targacept, Inc. (TRGT) Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease AstraZeneca and Targacept, Inc. today announced that results from... Read more...

PRESS RELEASE: Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases

Posted November 20, 2007

Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases Cambridge, MA and Zürich, Switzerland, November 20, 2007 – Biogen Idec and Neurimmune... Read more...

PRESS RELEASE: Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function

Posted November 13, 2007

Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive... Read more...

PRESS RELEASE: An Alzheimer’s Vaccine?

Posted November 13, 2007

Oklahoma City, Nov. 12, 2007 – Could a new vaccine be the key to stopping Alzheimer’s disease? A new research study from the Oklahoma Medical Research Foundation shows that immunization could... Read more...

PRESS RELEASE: Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease

Posted November 2, 2007

Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease MONTVALE, N.J., Nov. 2 -- Memory Pharmaceuticals Corp. today announced positive top-line data from the... Read more...

PRESS RELEASE: UCLA scientists pinpoint a possible physical origin of Alzheimer's disease

Posted October 23, 2007

UCLA scientists pinpoint a possible physical origin of Alzheimer's disease Discovery suggests new ways to treat disorder's cause, not just symptoms FINDINGS: For some time, scientists have blamed... Read more...